AJP - GI Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 276: G655-G665, 1999;
0193-1857/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carroll, R. E.
Right arrow Articles by Benya, R. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carroll, R. E.
Right arrow Articles by Benya, R. V.
Vol. 276, Issue 3, G655-G665, March 1999

Aberrant expression of gastrin-releasing peptide and its receptor by well-differentiated colon cancers in humans

Robert E. Carroll1,2, Kristina A. Matkowskyj1,2, Subrata Chakrabarti3, Thomas J. McDonald4, and Richard V. Benya1,2

1 Department of Medicine, University of Illinois at Chicago, and 2 Chicago Veterans Affairs Medical Center (West Side Division), Chicago, Illinois 60612; and Departments of 3 Pathology and 4 Medicine, University of Western Ontario, London, Ontario, Canada N6A 5A5

Epithelial cells lining the adult human colon do not normally express gastrin-releasing peptide (GRP) or its receptor (GRPR). In contrast, approximately one-third of human colon cancers and cancer cell lines have been shown to express GRP-binding sites. Because GRPR activation causes the proliferation of many cancer cell lines, GRP has been presumed to act as a clinically significant growth factor. Yet GRP has not been shown to be expressed by colon cancers in humans nor has the effect of GRP and/or GRPR coexpression on tumor behavior been investigated. We therefore determined GRP and GRPR expression by immunohistochemistry in 50 randomly selected colon cancers resected between 1980 and 1997, all 37 associated lymph node and liver metastases, and 20 polyps. Tumor sections studied were those that contained the margin and adjacent nonmalignant epithelium. Overall, 84% of cancers aberrantly expressed GRP or GRPR, with 62% expressing both ligand and receptor, whereas expression was not observed in adjacent normal epithelium. Consistent with the previously established mitogenic capabilities of GRP, tissues coexpressing GRP and GRPR were more likely to express proliferating cell nuclear antigen than tissues not expressing both ligand and receptor. Yet GRP/GRPR coexpression was seen with equal frequency in stage A as in stage D cancers and was only detected in 1 in 37 metastases. Furthermore, Kaplan-Meier analysis did not reveal any difference in patient survival between those whose tumors did or did not express GRP/GRPR. In contrast, GRP/GRPR coexpression was found in all well-differentiated tumor regions, whereas poorly differentiated tissues never coexpressed GRP/GRPR. Overall, these data indicate that, although GRP is a mitogen, it is not a clinically significant growth factor in human colon cancers. Rather, the strong association of GRP/GRPR coexpression with tumor differentiation raises the possibility that these proteins primarily act in vivo as morphogens.

adenocarcinoma; bombesin; mitogen; morphogen


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Taglia, D. Matusiak, K. A. Matkowskyj, and R. V. Benya
Gastrin-releasing peptide mediates its morphogenic properties in human colon cancer by upregulating intracellular adhesion protein-1 (ICAM-1) via focal adhesion kinase
Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G182 - G190.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Glover, R. Nathaniel, L. Shakir, C. Perrault, R. K. Anderson, R. Tran-Son-Tay, and R. V. Benya
Transient upregulation of GRP and its receptor critically regulate colon cancer cell motility during remodeling
Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1274 - G1282.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. Matusiak, S. Glover, R. Nathaniel, K. Matkowskyj, J. Yang, and R. V. Benya
Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon
Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G718 - G728.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
K. A. Matkowskyj, R. Cox, R. T. Jensen, and R. V. Benya
Quantitative Immunohistochemistry by Measuring Cumulative Signal Strength Accurately Measures Receptor Number
J. Histochem. Cytochem., February 1, 2003; 51(2): 205 - 214.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-C. Saurin, M. Fallavier, B. Sordat, J.-C. Gevrey, J.-A. Chayvialle, and J. Abello
Bombesin Stimulates Invasion and Migration of Isreco1 Colon Carcinoma Cells in a Rho-dependent Manner
Cancer Res., August 15, 2002; 62(16): 4829 - 4835.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. N. Lango, K. F. Dyer, V. W. Y. Lui, W. E. Gooding, C. Gubish, J. M. Siegfried, and J. R. Grandis
Gastrin-Releasing Peptide Receptor-Mediated Autocrine Growth in Squamous Cell Carcinoma of the Head and Neck
J Natl Cancer Inst, March 6, 2002; 94(5): 375 - 383.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. E. Carroll, D. Ostrovskiy, S. Lee, A. Danilkovich, and R. V. Benya
Characterization of Gastrin-Releasing Peptide and Its Receptor Aberrantly Expressed by Human Colon Cancer Cell Lines
Mol. Pharmacol., September 1, 2000; 58(3): 601 - 607.
[Abstract] [Full Text]


Home page
Cell Growth Differ.Home page
R. E. Carroll, K. A. Matkowskyj, M. S. Tretiakova, J. F. Battey, and R. V. Benya
Gastrin-releasing Peptide Is a Mitogen and a Morphogen in Murine Colon Cancer
Cell Growth Differ., July 1, 2000; 11(7): 385 - 393.
[Abstract] [Full Text]


Home page
J. Histochem. Cytochem.Home page
K. A. Matkowskyj, D. Schonfeld, and R. V. Benya
Quantitative Immunohistochemistry by Measuring Cumulative Signal Strength Using Commercially Available Software Photoshop and Matlab
J. Histochem. Cytochem., February 1, 2000; 48(2): 303 - 312.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y.-S. Guo, M. R. Hellmich, X. D. Wen, and C. M. Townsend Jr.
Activator Protein-1 Transcription Factor Mediates Bombesin-stimulated Cyclooxygenase-2 Expression in Intestinal Epithelial Cells
J. Biol. Chem., June 15, 2001; 276(25): 22941 - 22947.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online